Platelet transfusion therapy in neoplastic diseases

H. Al Mondhiry

Research output: Contribution to journalArticle

Abstract

Thrombocytopenic hemorrhage is a frequent and, at times, fatal complication of malignant disorders. During the last few years, prophylactic and therapeutic transfusions with platelet concentrates have resulted in significant improvement in the morbidity and mortality of patients with severe thrombocytopenia. Technical improvements in platelet procurement have made it possible to have platelet concentrates available on demand in an increasing number of institutions. The incidence of allosensitization is a major problem in repeatedly transfused patients. Infusion of HL A matched platelets seems to reduce the incidence of allo sensitization and improve the hemostatic effectiveness of infused platelets. The use of continuous flow centrifuge for platelet procurement has made the collection of large volumes of platelets from a single donor considerably easier.

Original languageEnglish (US)
Pages (from-to)20-23
Number of pages4
JournalClinical Bulletin
Volume3
Issue number1
StatePublished - Jan 1 1973

Fingerprint

Platelet Transfusion
Blood Platelets
Therapeutics
Incidence
Hemostatics
Thrombocytopenia
Tissue Donors
Hemorrhage
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Al Mondhiry, H. / Platelet transfusion therapy in neoplastic diseases. In: Clinical Bulletin. 1973 ; Vol. 3, No. 1. pp. 20-23.
@article{4e99bb7be40249f78edf267603b60917,
title = "Platelet transfusion therapy in neoplastic diseases",
abstract = "Thrombocytopenic hemorrhage is a frequent and, at times, fatal complication of malignant disorders. During the last few years, prophylactic and therapeutic transfusions with platelet concentrates have resulted in significant improvement in the morbidity and mortality of patients with severe thrombocytopenia. Technical improvements in platelet procurement have made it possible to have platelet concentrates available on demand in an increasing number of institutions. The incidence of allosensitization is a major problem in repeatedly transfused patients. Infusion of HL A matched platelets seems to reduce the incidence of allo sensitization and improve the hemostatic effectiveness of infused platelets. The use of continuous flow centrifuge for platelet procurement has made the collection of large volumes of platelets from a single donor considerably easier.",
author = "{Al Mondhiry}, H.",
year = "1973",
month = "1",
day = "1",
language = "English (US)",
volume = "3",
pages = "20--23",
journal = "Clinical Bulletin",
number = "1",

}

Al Mondhiry, H 1973, 'Platelet transfusion therapy in neoplastic diseases', Clinical Bulletin, vol. 3, no. 1, pp. 20-23.

Platelet transfusion therapy in neoplastic diseases. / Al Mondhiry, H.

In: Clinical Bulletin, Vol. 3, No. 1, 01.01.1973, p. 20-23.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Platelet transfusion therapy in neoplastic diseases

AU - Al Mondhiry, H.

PY - 1973/1/1

Y1 - 1973/1/1

N2 - Thrombocytopenic hemorrhage is a frequent and, at times, fatal complication of malignant disorders. During the last few years, prophylactic and therapeutic transfusions with platelet concentrates have resulted in significant improvement in the morbidity and mortality of patients with severe thrombocytopenia. Technical improvements in platelet procurement have made it possible to have platelet concentrates available on demand in an increasing number of institutions. The incidence of allosensitization is a major problem in repeatedly transfused patients. Infusion of HL A matched platelets seems to reduce the incidence of allo sensitization and improve the hemostatic effectiveness of infused platelets. The use of continuous flow centrifuge for platelet procurement has made the collection of large volumes of platelets from a single donor considerably easier.

AB - Thrombocytopenic hemorrhage is a frequent and, at times, fatal complication of malignant disorders. During the last few years, prophylactic and therapeutic transfusions with platelet concentrates have resulted in significant improvement in the morbidity and mortality of patients with severe thrombocytopenia. Technical improvements in platelet procurement have made it possible to have platelet concentrates available on demand in an increasing number of institutions. The incidence of allosensitization is a major problem in repeatedly transfused patients. Infusion of HL A matched platelets seems to reduce the incidence of allo sensitization and improve the hemostatic effectiveness of infused platelets. The use of continuous flow centrifuge for platelet procurement has made the collection of large volumes of platelets from a single donor considerably easier.

UR - http://www.scopus.com/inward/record.url?scp=0015717183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015717183&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 20

EP - 23

JO - Clinical Bulletin

JF - Clinical Bulletin

IS - 1

ER -